TickerFacts.

Lucid Diagnostics Inc. (LUCD): Capital Expenditures

Annual figures by period end, from SEC filings.

$197.0K
Year ended 2025-12-31
$315.0K
Trailing 12 months to 2026-06-30
-60.5%
3-year compound annual growth
$3.20M2021-12-31: $862.0K2022-12-31: $3.20M2024-12-31: $296.0K2025-12-31: $197.0K$197.0K
2021-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$197.0K-33.4%2026-03-25, From 2025-01-01
2024-12-31$296.0Kn/a2026-03-25, From 2024-01-01
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31$3.20M+271.2%2024-03-25, From 2022-01-01
2021-12-31$862.0Kn/a2022-04-06, From 2021-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Lucid Diagnostics Inc. (LUCD)2025-12-31$197.0K-33.4%
Cerenome, Inc. (CNSY)2025-12-31$67.0K-54.1%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$125.7K-45.8%
Tenon Medical, Inc. (TNON)2025-12-31$273.0K+46.8%
IceCure Medical Ltd. (ICCM)2025-12-31$36.0K-49.3%
Nuo Therapeutics, Inc. (AURX)2025-12-31$274.8K+77.3%
INVO Fertility, Inc. (IVF)2025-12-31$43.4K-76.4%
Beyond Air, Inc. (XAIR)2026-03-31$1.02M-82.6%
InspireMD, Inc. (NSPR)2025-12-31$1.66M+18.5%

Compare LUCD, CNSY, INBS, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗